您应享有的视觉自由

用 EVO ICL (EVO) 植入式 Collamer® 晶体矫正近视。

190

采由 Collamer® ——胶原蛋白聚合物制成

Collamer® 是 STAAR Surgical 的专利产品,具有生物相容性、稳定性、灵活性,并且与您的眼睛和谐共存。

325

柔软且富有弹性

EVO ICL 晶体由于其结构柔软灵活,易于植入眼内。除了获得清晰的视力,您不会感觉到它的存在。

Eye glasses top

矫正范围广泛

隐形眼镜和框架眼镜可能会带来麻烦和限制。EVO ICL 可以矫正范围广泛 (-3D到-20D) 的近视

仅需 30分钟

EVO ICL 手术是微创手术,晶体通过一个小切口植入,手术时间和恢复时间较短。 EVO ICL 在全球范围内已销售超过2,000,000片,正迅速成为世界各地患者的视力矫正选择。

关于手术
Fa D desktop

用EVO ICL 解锁自由视界,您准备好了吗?立即查找医生

参考

1Patient Survey, STAAR Surgical ICL Data Registry, 2018

2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.

3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council